Steven K. Libutti, MD, FACS, was named Director of Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences in January 2017. He also serves as Senior Vice President of Oncology Services for RWJBarnabas Health; is a tenured Professor of Surgery at Rutgers Robert Wood Johnson Medical School; and is an Affiliated Distinguished Professor in Genetics, Rutgers School of Arts and Sciences. Dr. Libutti graduated from Harvard College and received his M.D. from the College of Physicians and Surgeons of Columbia University. Following his residency in Surgery, he completed a fellowship in Surgical Oncology and Endocrine Surgery at the National Cancer Institute (NCI).
Dr. Libutti’s clinical practice focuses on gastrointestinal malignancies including cancers of the liver and pancreas. His research focuses on developing novel cancer therapies through an understanding of the tumor microenvironment. He is studying the interaction between tumor cells and the components of the tumor microenvironment. His work also focuses on a better understanding of the tumor suppressor genes MEN1 and FILIP1L. Dr. Libutti is a leader in regional cancer therapy, the management of endocrine tumors and tumor targeted gene therapy. He is a past President of the American Association of Endocrine Surgeons, serves as the Editor-in-Chief of the Springer-Nature Journal Cancer Gene Therapy and holds seven U.S. patents.